Research

ISCI Research

Basic Cell Biology, Blood, Bone & Skin, Cancer, Cardiovascular, Diabetes and Nervous System.

Clinical Trials

Clinical Trials

Phase I/II clinical trials testing mesenchymal stem cells (MSC) in cardiology and wound care.

Leadership

ISCI Leadership

Renowned physician-scientists set a vision for the future of regenerative medicine.

Latest News

New Study Finds Stem Cell Therapy via Intra-Carotid Artery Infusion Safe for Treatment of Stroke

A yearlong study of patients who had suffered from ischemic strokes, led by physician-scientists at the Interdisciplinary Stem Cell Institute at the Miller School of Medicine, has found that stem cells can be safely infused to the brain through the carotid artery within two weeks after a stroke.

Read more on the Miller School Web site »

Miami CFAR, ISCI and Sylvester Researchers Receive Grant to Study Stem Cell Role in Kaposi’s Sarcoma

An interdisciplinary team of Miller School of Medicine researchers has received a $1.8 million grant from the National Cancer Institute to study the role of stem cells in Kaposi’s sarcoma oncogenesis and therapy.

Read more on the Miller School Web site »

Study Promotes Bone Growth as Possible Therapy for Osteoporosis and Obesity

Joshua Hare, M.D., Director of the Interdisciplinary Stem Cell Institute at the Miller School of Medicine, has co-authored a new study in the Journal of Clinical Investigation demonstrating that mesenchymal stem cells (MSCs) create bone cells by triggering a biochemical switch that determines whether cells will become fat or bone.

Read more on the Miller School Web site »